Computed Tomography (CT)-Guided Biopsy Market Report 2026

Computed Tomography (CT)-Guided Biopsy Market Overview

• Computed Tomography (CT)-Guided Biopsy market size has reached to $0.77 billion in 2025 • Expected to grow to $1.06 billion in 2030 at a compound annual growth rate (CAGR) of 6.6% • Growth Driver: Surge In Incidence Of Cancer Fueling The Growth Of The Market Due To Higher Demand For Early And Accurate Tissue Diagnosis • Market Trend: Real-Time CT Navigation Systems Enhancing Precision And Safety In CT-Guided Biopsy Procedures • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Computed Tomography (CT)-Guided Biopsy Market?

Computed tomography (CT)-guided biopsy is a minimally invasive diagnostic procedure that utilizes real-time computed tomography imaging to accurately guide a needle into targeted areas within the body for tissue sample collection. This technique enables precise localization of lesions in complex or hard-to-reach anatomical regions, improving diagnostic accuracy while minimizing damage to surrounding healthy tissues. It is widely used to evaluate abnormalities such as tumors, infections, and inflammatory conditions by facilitating detailed histopathological analysis. The main biopsy techniques of CT-guided biopsy include core needle biopsy, fine needle aspiration biopsy, vacuum-assisted biopsy, and trephine or bone biopsy. Core needle biopsy refers to a minimally invasive procedure that uses a hollow needle under computed tomography guidance to extract a cylindrical tissue sample for detailed pathological examination. These procedures involve target organs such as lung, liver, kidney, bone, pancreas, and other target organs and they utilize computed tomography modalities such as conventional computed tomography, computed tomography fluoroscopy, cone-beam computed tomography, and spectral or dual-energy computed tomography. The needle systems include coaxial systems, non-coaxial systems, semi-automated systems, and fully automated systems, while end users include hospitals, imaging centers, and ambulatory surgical centers.

What Is The Computed Tomography (CT)-Guided Biopsy Market Growth Forecast?

The computed tomography (CT)-guided biopsy market size is expected to see strong growth in the next few years.It will grow to $1.06 billion by 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing demand for early-stage cancer detection, rising adoption of precision medicine-based diagnostics, expansion of outpatient diagnostic centers, growing aging population requiring diagnostic interventions, advancements in biopsy needle technologies and procedural safety.Major trends in the forecast period include increasing adoption of minimally invasive diagnostic procedures for early and accurate disease detection, rising demand for image-guided precision interventions in oncology and infection diagnosis, growing preference for outpatient and ambulatory biopsy procedures to reduce hospital burden, expansion of interventional radiology departments improving access to ct-guided procedures, increasing focus on early cancer screening and tissue-based diagnostics in clinical workflows.

Global Computed Tomography (CT)-Guided Biopsy Market Segmentation

1) By Biopsy Technique: Core Needle Biopsy, Fine Needle Aspiration, Vacuum-Assisted, Trephine Or Bone 2) By Target Organ: Lung, Liver, Kidney, Bone, Pancreas, Other Target Organs 3) By CT Modality: Conventional CT, CT-Fluoroscopy, Cone-Beam CT, Spectral Or Dual-Energy CT 4) By Needle System: Coaxial Systems, Non-Coaxial, Semi-Automated, Fully Automated 5) By End User: Hospitals, Imaging Centers, Ambulatory Surgical Centers Subsegments: 1) By Core Needle Biopsy: Automated Core Needle Biopsy, Image Guided Core Needle Biopsy, Coaxial Core Needle Biopsy, Single Use Core Needle Biopsy 2) By Fine Needle Aspiration: Image Guided Fine Needle Aspiration, Endoscopic Fine Needle Aspiration, Percutaneous Fine Needle Aspiration, Ultrasound Assisted Fine Needle Aspiration 3) By Vacuum-Assisted: Image Guided Vacuum-Assisted Biopsy, Stereotactic Vacuum-Assisted Biopsy, Ultrasound Guided Vacuum-Assisted Biopsy, High Volume Vacuum-Assisted Biopsy 4) By Trephine Or Bone: Bone Marrow Trephine Biopsy, Image Guided Bone Biopsy, Percutaneous Bone Biopsy, Orthopedic Bone Biopsy

What Is The Driver Of The Computed Tomography (CT)-Guided Biopsy Market?

The rising incidence of cancer is expected to propel the growth of the CT-guided biopsy market going forward.The increase in cancer incidence is primarily driven by the expanding aging population, as older individuals are at a higher risk of developing solid tumors that require accurate and timely diagnostic confirmation.CT-guided biopsy supports this need by enabling precise tissue sampling from deep-seated or anatomically complex lesions, particularly in organs such as the lung, liver, pancreas, kidney, and bone, where imaging alone is often insufficient for definitive diagnosis and treatment planning.For instance, in April 2024, according to the International Agency for Research on Cancer, a France-based intergovernmental organization forming part of the World Health Organization, there were approximately 20 million new cancer cases and nearly 10 million cancer-related deaths globally in 2022.Demographic projections indicate that the annual number of new cancer cases is expected to reach 35 million by 2050, representing a 77% increase compared to 2022.Therefore, the rising incidence of cancer is driving the growth of the CT-guided biopsy market.

Key Players In The Global Computed Tomography (CT)-Guided Biopsy Market

Major companies operating in the computed tomography (ct)-guided biopsy market are Samsung Electronics, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Stryker Corporation, Medtronic PLC, Boston Scientific Inc., Becton Dickinson and Company, Siemens Healthineers, Agilent Technologies Inc., GE HealthCare Technologies, Canon Inc., Zimmer Biomet Holdings Inc., Terumo Corporation, Fujifilm Corporation, Illumina Inc., Koninklijke Philips N. V., Olympus Corporation, Hologic Inc., Teleflex Incorporated, Sysmex Corporation, QIAGEN N. V., Bio-Rad Laboratories Inc., Shimadzu Corporation, Merit Medical Systems Inc., Guerbet (GBT. PA)

Global Computed Tomography (CT)-Guided Biopsy Market Trends and Insights

Major companies operating in the CT-guided biopsy market are focusing on the development of advanced navigation technologies, such as real-time CT navigation systems, to enhance procedural accuracy, reduce radiation exposure, and improve workflow efficiency. Real-time CT navigation systems are integrated imaging and guidance platforms that utilize 3D visualization and electromagnetic tracking to assist clinicians in accurately guiding biopsy needles to target lesions while minimizing the need for repeated imaging. For instance, in April 2023, GE HealthCare, a US-based medical technology company, introduced its CT-Navigation solution. The system provides real-time 3D CT imaging for stereotactic needle guidance across procedures such as biopsies, ablations, and drainage. It incorporates electromagnetic navigation technology that enables complex needle trajectories, allowing clinicians to avoid critical anatomical structures. Additionally, the solution reduces radiation dose and procedure time by minimizing the need for multiple control scans while improving targeting accuracy, thereby enhancing safety and efficiency in interventional procedures.

What Are Latest Mergers And Acquisitions In The Computed Tomography (CT)-Guided Biopsy Market?

In April 2023, GE HealthCare, a United States-based medical technology company, acquired IMACTIS for an undisclosed amount. Through this acquisition, GE HealthCare strengthened its interventional guidance capabilities by integrating CT-based needle navigation technology to enhance procedural accuracy, workflow efficiency, and radiation management. IMACTIS is a France-based provider of CT-guided interventional navigation solutions for minimally invasive procedures.

Regional Insights

North America was the largest region in the CT-guided biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Computed Tomography (CT)-Guided Biopsy Market?

The CT-guided biopsy market includes revenues earned by entities by providing services such as ultrasound-guided biopsy, MRI-guided biopsy, stereotactic biopsy, fluoroscopy-guided biopsy, image-guided fine needle aspiration, core needle biopsy services, and interventional radiology biopsy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

What is the Market Assessment and Strategic Outlook for the Computed Tomography (CT)-Guided Biopsy Industry?

The computed tomography (ct)-guided biopsy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the computed tomography (ct)-guided biopsy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

What is the Market Assessment and Strategic Outlook for the Computed Tomography (CT)-Guided Biopsy Market Report 2026?

The computed tomography (CT)-guided biopsy market research report is one of a series of new reports from The Business Research Company that provides computed tomography (CT)-guided biopsy market statistics, including computed tomography (CT)-guided biopsy industry global market size, regional shares, competitors with a computed tomography (CT)-guided biopsy market share, detailed computed tomography (CT)-guided biopsy market segments, market trends and opportunities, and any further data you may need to thrive in the computed tomography (CT)-guided biopsy industry. This computed tomography (CT)-guided biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.